New York, NY -- (SBWIRE) -- 01/21/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Immunomedics, Inc (NASDAQ:IMMU), Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU), XOMA Corp (NASDAQ:XOMA),Paramount Gold and Silver Corp (NYSEMKT:PZG)
Immunomedics, Inc (NASDAQ:IMMU) showed a volume of 1.14 million shares by the end of last trade whereas the average volume of the stock remained 1.28 million shares. The stock opened the session at $5.74 but then moved to $5.51. At that price, the stock showed a negative performance of -3.33%. Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
Will IMMU Get Buyers Even After The Recent Rally? Find Out Here
Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU) opened the session at $6.51 and closed the session at $6.48. The stock showed a positive performance of 0.31% in previous trading session. Traded with volume of 1.40 million shares in the prior session and the average volume of the stock remained 1.34 million shares. Mitsubishi UFJ Financial Group, Inc. is a Japan-based company mainly engaged in the banking business. The Company is also involved in trust banking business, security business, credit card business, leasing business and other businesses.
For How Long MTU will fight for Profitability? Read This Trend Analysis report
XOMA Corp (NASDAQ:XOMA) opened the session at $8.40and closed the session at $8.20. The stock showed a negative performance of -2.15% in previous trading session. Traded with volume of 1.39 million shares in the prior session and the average volume of the stock remained 2.49 million shares. The beta of the stock remained 2.41. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
Why Should Investors Buy XOMA After the Recent Fall? Just Go Here and Find Out
Paramount Gold and Silver Corp (NYSEMKT:PZG) the stock advanced 8.49% and finished the session at $1.15. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 858,443.00 shares. The beta of the stock remained 1.17. Paramount Gold and Silver Corp. (Paramount) is an exploration stage mining company with projects in northern Nevada and Chihuahua, Mexico. Through its wholly owned Mexican subsidiary, Paramount Gold de Mexico S.A. de C.V., the Company owns a 100% interest in the San Miguel property.
Will PZG Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)